The human microbiome and gut–liver axis in people living with HIV

Lynch SV, Pedersen O. The human intestinal microbiome in health and disease. N Engl J Med. 2016;375(24):2369–79. https://doi.org/10.1056/NEJMra1600266.

Article  CAS  PubMed  Google Scholar 

Ristig M, Drechsler H, Powderly WG. Hepatic steatosis and HIV infection. AIDS Patient Care STDS. 2005;19(6):356–65. https://doi.org/10.1089/apc.2005.19.356.

Article  PubMed  Google Scholar 

Aepfelbacher JA, Balmaceda J, Purdy J, et al. Increased prevalence of hepatic steatosis in young adults with lifelong HIV. J Infect Dis. 2019;220(2):266–9. https://doi.org/10.1093/infdis/jiz096.

Article  PubMed  PubMed Central  Google Scholar 

Smith CJ, Ryom L, Weber R, et al. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration. Lancet. 2014;384(9939):241–8. https://doi.org/10.1016/S0140-6736(14)60604-8.

Article  PubMed  Google Scholar 

Bica I, McGovern B, Dhar R, et al. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis. 2001;32(3):492–7. https://doi.org/10.1086/318501.

Article  CAS  PubMed  Google Scholar 

Gardner AR, Ma Y, Bacchetti P, et al. Longitudinal assessment of the enhanced liver fibrosis score in the era of contemporary HIV and hepatitis C virus treatment. J Infect Dis. 2022:jiac315. https://doi.org/10.1093/infdis/jiac315.

Price JC, Ma Y, Kuniholm MH, et al. Human immunodeficiency virus is associated with elevated FibroScan-Aspartate Aminotransferase (FAST) score. Clin Infect Dis. 2022;75(12):2119–27. https://doi.org/10.1093/cid/ciac337.

Maurice J, Manousou P. Non-alcoholic fatty liver disease. Clin Med (Lond). 2018;18(3):245–50. https://doi.org/10.7861/clinmedicine.18-3-245.

Article  PubMed  Google Scholar 

Kardashian A, Peters MG, Tien PC, Price JC. The pathogenesis of liver disease in people living with human immunodeficiency virus: the emerging role of the microbiome. Clin Liver Dis (Hoboken). 2020;15(1):46–51. https://doi.org/10.1002/cld.880.

Article  PubMed  Google Scholar 

Dillon SM, Frank DN, Wilson CC. The gut microbiome and HIV-1 pathogenesis: a two-way street. AIDS. 2016;30(18):2737–51. https://doi.org/10.1097/QAD.0000000000001289.

Article  CAS  PubMed  Google Scholar 

Chelakkot C, Ghim J, Ryu SH. Mechanisms regulating intestinal barrier integrity and its pathological implications. Exp Mol Med. 2018;50(8):1–9. https://doi.org/10.1038/s12276-018-0126-x.

Article  CAS  PubMed  Google Scholar 

Blaschitz C, Raffatellu M. Th17 cytokines and the gut mucosal barrier. J Clin Immunol. 2010;30(2):196–203. https://doi.org/10.1007/s10875-010-9368-7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hunt PW, Sinclair E, Rodriguez B, et al. Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection. J Infect Dis. 2014;210(8):1228–38. https://doi.org/10.1093/infdis/jiu238.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schuetz A, Deleage C, Sereti I, et al. Initiation of ART during early acute HIV infection preserves mucosal Th17 function and reverses HIV-related immune activation. PLOS Pathogens. 2014;10(12):e1004543. https://doi.org/10.1371/journal.ppat.1004543.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Serrano-Villar S, Sainz T, Lee SA, et al. HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality. PLoS Pathog. 2014;10(5):e1004078. https://doi.org/10.1371/journal.ppat.1004078.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Burgener A, McGowan I, Klatt NR. HIV and mucosal barrier interactions: consequences for transmission and pathogenesis. Curr Opin Immunol. 2015;36:22–30. https://doi.org/10.1016/j.coi.2015.06.004.

Article  CAS  PubMed  Google Scholar 

Raffatellu M, Santos RL, Verhoeven DE, et al. Simian immunodeficiency virus–induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat Med. 2008;14(4):421–8. https://doi.org/10.1038/nm1743.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kumar P, Monin L, Castillo P, et al. Intestinal interleukin-17 receptor signaling mediates reciprocal control of the gut microbiota and autoimmune inflammation. Immunity. 2016;44(3):659–71. https://doi.org/10.1016/j.immuni.2016.02.007.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Estes JD, Harris LD, Klatt NR, et al. Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections. PLoS Pathog. 2010;6(8):e1001052. https://doi.org/10.1371/journal.ppat.1001052.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Estes JD, Wietgrefe S, Schacker T, et al. Simian immunodeficiency virus-induced lymphatic tissue fibrosis is mediated by transforming growth factor beta 1-positive regulatory T cells and begins in early infection. J Infect Dis. 2007;195(4):551–61. https://doi.org/10.1086/510852.

Article  CAS  PubMed  Google Scholar 

Somsouk M, Estes JD, Deleage C, et al. Gut epithelial barrier and systemic inflammation during chronic HIV infection. AIDS. 2015;29(1):43–51. https://doi.org/10.1097/QAD.0000000000000511.

Article  CAS  PubMed  Google Scholar 

Chitre AS, Kattah MG, Rosli YY, et al. A20 upregulation during treated HIV disease is associated with intestinal epithelial cell recovery and function. PLoS Pathog. 2018;14(3):e1006806. https://doi.org/10.1371/journal.ppat.1006806.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006;12(12):1365–71. https://doi.org/10.1038/nm1511.

Article  CAS  PubMed  Google Scholar 

Sandler NG, Wand H, Roque A, et al. Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis. 2011;203(6):780–90. https://doi.org/10.1093/infdis/jiq118.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vujkovic-Cvijin I, Dunham RM, Iwai S, et al. Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism. Sci Transl Med. 2013;5(193):193ra91. https://doi.org/10.1126/scitranslmed.3006438.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lozupone CA, Li M, Campbell TB, et al. Alterations in the gut microbiota associated with HIV-1 infection. Cell Host Microbe. 2013;14(3):329–39. https://doi.org/10.1016/j.chom.2013.08.006.

Article  CAS  PubMed  Google Scholar 

Nganou-Makamdop K, Talla A, Sharma AA, et al. Translocated microbiome composition determines immunological outcome in treated HIV infection. Cell. 2021;184(15):3899-3914.e16. https://doi.org/10.1016/j.cell.2021.05.023.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bhat M, Arendt BM, Bhat V, Renner EL, Humar A, Allard JP. Implication of the intestinal microbiome in complications of cirrhosis. World J Hepatol. 2016;8(27):1128–36. https://doi.org/10.4254/wjh.v8.i27.1128.

Article  PubMed  PubMed Central  Google Scholar 

Tripathi A, Debelius J, Brenner DA, et al. The gut-liver axis and the intersection with the microbiome. Nat Rev Gastroenterol Hepatol. 2018;15(7):397–411. https://doi.org/10.1038/s41575-018-0011-z.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hyun J, McMahon RS, Lang AL, et al. HIV and HCV augments inflammatory responses through increased TREM-1 expression and signaling in Kupffer and Myeloid cells. PLoS Pathog. 2019;15(7):e1007883. https://doi.org/10.1371/journal.ppat.1007883.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Le Roy T, Llopis M, Lepage P, et al. Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice. Gut. 2013;62(12):1787–94. https://doi.org/10.1136/gutjnl-2012-303816.

Article  CAS  PubMed  Google Scholar 

Vrieze A, Van Nood E, Holleman F, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology. 2012;143(4):913-916.e7. https://doi.org/10.1053/j.gastro.2012.06.031.

Article  CAS  PubMed  Google Scholar 

Boursier J, Mueller O, Barret M, et al. The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota. Hepatology. 2016;63(3):764–75. https://doi.org/10.1002/hep.28356.

Article  CAS  PubMed  Google Scholar 

Csak T, Velayudham A, Hritz I, et al. Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice. Am J Physiol Gastrointest Liver Physiol. 2011;300(3):G433-441. https://doi.org/10.1152/ajpgi.00163.2009.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fianchi F, Liguori A, Gasbarrini A, Grieco A, Miele L. Nonalcoholic fatty liver disease (NAFLD) as model of gut–liver axis interaction: from pathophysiology to potential target of treatment for personalized therapy. Int J Mol Sci. 2021;22(12):6485. https://doi.org/10.3390/ijms22126485.

Article  CAS  PubMed  PubMed Central 

留言 (0)

沒有登入
gif